Pulse Biosciences, Inc. (PLSE) Free cash flow 2016–2025
Pulse Biosciences, Inc. (PLSE) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$54.4MFY2025 · since FY2016: -$8.1M → -$54.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$54.4M | -49.3% |
| FY2024 | -$36.5M | -10.0% |
| FY2023 | -$33.2M | +30.1% |
| FY2022 | -$47.4M | +13.1% |
| FY2021 | -$54.5M | -52.3% |
| FY2020 | -$35.8M | -2.9% |
| FY2019 | -$34.8M | -43.9% |
| FY2018 | -$24.2M | -77.2% |
| FY2017 | -$13.6M | -68.1% |
| FY2016 | -$8.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PLSE financial trends
PLSE RevenuePLSE Net incomePLSE Net marginPLSE Gross profitPLSE Gross marginPLSE Operating incomePLSE Operating marginPLSE Operating cash flowPLSE Capital expendituresPLSE Return on equityPLSE Stock buybacksPLSE Dividends paidPLSE Total assetsPLSE Total liabilitiesPLSE Shareholders’ equityPLSE overview →